{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T05:21:46Z","timestamp":1736659306657,"version":"3.32.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,11]]},"DOI":"10.7759\/cureus.77288","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:55:46Z","timestamp":1736618146000},"source":"Crossref","is-referenced-by-count":0,"title":["Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With Type 2 Diabetes and COVID-19 in Morocco?"],"prefix":"10.7759","author":[{"given":"Bouchra","family":"Benfathallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Cherkani Hassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"El Hilali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Redouane","family":"Abouqal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La\u00efla","family":"Benchekroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16105","article-title":"The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes","volume":"288","author":"Tong ZW","year":"2021","unstructured":"Tong ZW, Grant E, Gras S, et al.. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes. FEBS J. 2021, 288:5042-54. 10.1111\/febs.16105","journal-title":"FEBS J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman N","year":"2020","unstructured":"Holman N, Knighton P, Kar P, et al.. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020, 8:823-33. 10.1016\/S2213-8587(20)30271-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang L","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir Med. 2020, 8:e21. 10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28100","article-title":"Bidirectional causal associations between type 2 diabetes and COVID-19","volume":"95","author":"Cao H","year":"2023","unstructured":"Cao H, Baranova A, Wei X, Wang C, Zhang F. Bidirectional causal associations between type 2 diabetes and COVID-19. J Med Virol. 2023, 95:e28100. 10.1002\/jmv.28100","journal-title":"J Med Virol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab067","article-title":"Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes","volume":"106","author":"Wang J","year":"2021","unstructured":"Wang J, Cooper JM, Gokhale K, et al.. Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes. J Clin Endocrinol Metab. 2021, 106:1255-68. 10.1210\/clinem\/dgab067","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071874","article-title":"Is metformin use associated with a more favorable Covid-19 course in people with diabetes?","volume":"13","author":"Silverii GA","year":"2024","unstructured":"Silverii GA, Fumagalli C, Rozzini R, Milani M, Mannucci E, Marchionni N. Is metformin use associated with a more favorable Covid-19 course in people with diabetes?. J Clin Med. 2024, 13:1874. 10.3390\/jcm13071874","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-2539","article-title":"Metformin for treatment of acute COVID-19: systematic review of clinical trial data against SARS-CoV-2","volume":"46","author":"Erickson SM","year":"2023","unstructured":"Erickson SM, Fenno SL, Barzilai N, et al.. Metformin for treatment of acute COVID-19: systematic review of clinical trial data against SARS-CoV-2. Diabetes Care. 2023, 46:1432-42. 10.2337\/dc22-2539","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis","volume":"2","author":"Bramante CT","year":"2021","unstructured":"Bramante CT, Ingraham NE, Murray TA, et al.. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2021, 2:e34-41. 10.1016\/S2666-7568(20)30033-7","journal-title":"Lancet Healthy Longev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282210","article-title":"Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis","volume":"18","author":"Ma Z","year":"2023","unstructured":"Ma Z, Krishnamurthy M. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis. PLoS One. 2023, 18:e0282210. 10.1371\/journal.pone.0282210","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.704666","article-title":"Metformin in patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Li Y","year":"2021","unstructured":"Li Y, Yang X, Yan P, Sun T, Zeng Z, Li S. Metformin in patients with COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2021, 8:704666. 10.3389\/fmed.2021.704666","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.101216","article-title":"Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19","volume":"47","author":"Lalau JD","year":"2021","unstructured":"Lalau JD, Al-Salameh A, Hadjadj S, et al.. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2021, 47:101216. 10.1016\/j.diabet.2020.101216","journal-title":"Diabetes Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","volume":"103","author":"Luo P","year":"2020","unstructured":"Luo P, Qiu L, Liu Y, et al.. Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am J Trop Med Hyg. 2020, 103:69-72. 10.4269\/ajtmh.20-0375","journal-title":"Am J Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119371","article-title":"Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: a multicentral retrospective study","volume":"275","author":"Cheng X","year":"2021","unstructured":"Cheng X, Xin S, Chen Y, et al.. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: a multicentral retrospective study. Life Sci. 2021, 275:119371. 10.1016\/j.lfs.2021.119371","journal-title":"Life Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein SR","year":"2020","unstructured":"Bornstein SR, Rubino F, Khunti K, et al.. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020, 8:546-50. 10.1016\/S2213-8587(20)30152-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108268","article-title":"Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?","volume":"165","author":"Singh AK","year":"2020","unstructured":"Singh AK, Singh R. Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?. Diabetes Res Clin Pract. 2020, 165:108268. 10.1016\/j.diabres.2020.108268","journal-title":"Diabetes Res Clin Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108183","article-title":"Metformin in COVID-19: a possible role beyond diabetes","volume":"164","author":"Sharma S","year":"2020","unstructured":"Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res Clin Pract. 2020, 164:108183. 10.1016\/j.diabres.2020.108183","journal-title":"Diabetes Res Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 severity: a literature review","volume":"31","author":"Gallo Marin B","year":"2021","unstructured":"Gallo Marin B, Aghagoli G, Lavine K, et al.. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021, 31:1-10. 10.1002\/rmv.2146","journal-title":"Rev Med Virol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2021.03.004","article-title":"Therapeutic potential of metformin in COVID-19: reasoning for its protective role","volume":"29","author":"Samuel SM","year":"2021","unstructured":"Samuel SM, Varghese E, B\u00fcsselberg D. Therapeutic potential of metformin in COVID-19: reasoning for its protective role. Trends Microbiol. 2021, 29:894-907. 10.1016\/j.tim.2021.03.004","journal-title":"Trends Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae477","article-title":"Renal protective effect of metformin in type 2 diabetes patients","author":"Wang HH","year":"2024","unstructured":"Wang HH, Lin SH, Hung SY, et al.. Renal protective effect of metformin in type 2 diabetes patients. J Clin Endocrinol Metab. 2024, 477. 10.1210\/clinem\/dgae477","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111454","article-title":"Mechanism and application of metformin in kidney diseases: an update","volume":"138","author":"Song A","year":"2021","unstructured":"Song A, Zhang C, Meng X. Mechanism and application of metformin in kidney diseases: an update. Biomed Pharmacother. 2021, 138:111454. 10.1016\/j.biopha.2021.111454","journal-title":"Biomed Pharmacother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.11.006","article-title":"The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis","volume":"14","author":"Lukito AA","year":"2020","unstructured":"Lukito AA, Pranata R, Henrina J, Lim MA, Lawrensia S, Suastika K. The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020, 14:2177-83. 10.1016\/j.dsx.2020.11.006","journal-title":"Diabetes Metab Syndr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.02.022","article-title":"Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA","volume":"15","author":"Ghany R","year":"2021","unstructured":"Ghany R, Palacio A, Dawkins E, et al.. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA. Diabetes Metab Syndr. 2021, 15:513-8. 10.1016\/j.dsx.2021.02.022","journal-title":"Diabetes Metab Syndr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12897","article-title":"Risk of metformin in patients with type 2 diabetes with COVID-19: a preliminary retrospective report","volume":"13","author":"Gao Y","year":"2020","unstructured":"Gao Y, Liu T, Zhong W, Liu R, Zhou H, Huang W, Zhang W. Risk of metformin in patients with type 2 diabetes with COVID-19: a preliminary retrospective report. Clin Transl Sci. 2020, 13:1055-9. 10.1111\/cts.12897","journal-title":"Clin Transl Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201662","article-title":"Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19","volume":"387","author":"Bramante CT","year":"2022","unstructured":"Bramante CT, Huling JD, Tignanelli CJ, et al.. Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19. N Engl J Med. 2022, 387:599-610. 10.1056\/NEJMoa2201662","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.10.012","article-title":"Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process","volume":"81","author":"Watson KE","year":"2023","unstructured":"Watson KE, Dhaliwal K, Robertshaw S, et al.. Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process. Am J Kidney Dis. 2023, 81:564-74. 10.1053\/j.ajkd.2022.10.012","journal-title":"Am J Kidney Dis"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101425","article-title":"ACE2, metformin, and COVID-19","volume":"23","author":"Malhotra A","year":"2020","unstructured":"Malhotra A, Hepokoski M, McCowen KC, Shyy JY. ACE2, metformin, and COVID-19. Iscience. 2020, 23:","journal-title":"Iscience"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052596","article-title":"Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history","volume":"22","author":"Kaneto H","year":"2021","unstructured":"Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history. Int J Mol Sci. 2021, 22:2596. 10.3390\/ijms22052596","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2020.100290","article-title":"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection","volume":"19","author":"Hariyanto TI","year":"2020","unstructured":"Hariyanto TI, Kurniawan A. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med. 2020, 19:100290. 10.1016\/j.obmed.2020.100290","journal-title":"Obes Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101359","article-title":"Protection by metformin against severe COVID-19: an in-depth mechanistic analysis","volume":"48","author":"Wiernsperger N","year":"2022","unstructured":"Wiernsperger N, Al-Salameh A, Cariou B, Lalau JD. Protection by metformin against severe COVID-19: an in-depth mechanistic analysis. Diabetes Metab. 2022, 48:101359. 10.1016\/j.diabet.2022.101359","journal-title":"Diabetes Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1002","article-title":"Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway","volume":"154","author":"Cao X","year":"2013","unstructured":"Cao X, Li H, Tao H, et al.. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinol. 2013, 154:3680-9. 10.1210\/en.2013-1002","journal-title":"Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"Zumla A","year":"2020","unstructured":"Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020, 395:e35-6. 10.1016\/S0140-6736(20)30305-6","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325967-does-the-consumption-of-metformin-correlate-with-a-reduction-in-mortality-among-patients-with-type-2-diabetes-and-covid-19-in-morocco","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:55:48Z","timestamp":1736618148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325967-does-the-consumption-of-metformin-correlate-with-a-reduction-in-mortality-among-patients-with-type-2-diabetes-and-covid-19-in-morocco"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.77288","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,11]]}}}